Home/Photys Therapeutics/Brian Fenton

BF

Brian Fenton

President and CEO

Photys Therapeutics

Therapeutic Areas

Oncology Autoimmune and Inflammatory Diseases Cardiometabolic Diseases

Photys Therapeutics Pipeline

Drug	Indication	Phase
p53-Y220C-BET Bifunctional	p53-Y220C-mutant cancers	Preclinical
IRAK4 Degrader	Oncology/Immunology (licensed to Polymed)	Phase 1-ready

Leadership Team at Photys Therapeutics

Alexandra Joseph, PhD

Chief Scientific Officer

Amit Choudhary, PhD

Scientific Founder

View full Photys Therapeutics profile